✦ LIBER ✦

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

✍ Scribed by Hiroji Iwata; Seigo Nakamura; Masakazu Toi; Eisei Shin; Norikazu Masuda; Shinji Ohno; Yuichi Takatsuka; Kazufumi Hisamatsu; Kosuke Yamazaki; Mikihiro Kusama; Hiroshi Kaise; Yasuyuki Sato; Katsumasa Kuroi; Futoshi Akiyama; Hitoshi Tsuda; Masafumi Kurosumi

Book ID: 111854239
Publisher: Springer Japan
Year: 2005
Tongue: English
Weight: 497 KB
Volume: 12
Category: Article
ISSN: 1340-6868
DOI: 10.2325/jbcs.12.99

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

A phase II study of metronomic paclitaxe

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

✍ Masuda, N.; Higaki, K.; Takano, T.; Matsunami, N.; Morimoto, T.; Ohtani, S.; Miz 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 519 KB

Randomized phase II study of weekly pacl

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

✍ Ando, Masashi; Yamauchi, Hideko; Aogi, Kenjiro; Shimizu, Satoru; Iwata, Hiroji; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 296 KB

Randomized trial of preoperative docetax

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

✍ Ohno, S.; Chow, L. W. C.; Sato, N.; Masuda, N.; Sasano, H.; Takahashi, F.; Bando 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 352 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views